Sort
53,477 grants matching “addiction”
Models of SBIRT for Opioid Dependent Patients in the Emergency Department
$925,186Gail D'onofrio · Yale University · R01 · FY2008 · DA
SYNPLA: A scaleable method for monitoring circuit-specific learning-induced changes in synaptic strength
$924,725Anthony M Zador · Cold Spring Harbor Laboratory · U01 · FY2017 · MH
Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse
$924,518Tong H Lee · Duke University · RC2 · FY2009 · DA
Cocaine addiction medication EMB-001
$924,166Nicholas E. Goeders · Louisiana State Univ Hsc Shreveport · R01 · FY2012 · DA
Use of Next-Gen Sequencing to Identify Genetic Variants that Influence compulsive Oxycodone Intake in Outbred Rats
$924,074Olivier George · University Of California, San Diego · U01 · FY2023 · DA
Genes contributing for nicotine dependence in humans
$923,267Kari Stefansson · Decode Genetics, Ehf · R01 · FY2015 · DA
Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and E-cigarettes Among Daily and Non-Daily Smokers on Abuse Liability
$923,215Paul Michael Cinciripini · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · DA
Clinical Trial Network: Southwest Node
$923,070Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2009 · DA
Identification and functional characterization of colorectal cancer genes
$922,870Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A Human Antibody as an Immunotherapy for Cocaine Abuse
$922,721Andrew B Norman · P2d, Inc. · R44 · FY2008 · DA
Identifying Genetic Variants Associated with Opioid Overdose Mortality
$922,672Elliot C Nelson · Washington University · R01 · FY2022 · DA
Developing Novel Therapies for High Risk Pediatric Cancers
$922,580Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
DAT Selective Inhibitor As Cocaine Medication
$922,578Novascreen Biosciences Corporation · R44 · FY2005 · DA
MOR/DOR Heterodimer Antagonists: A Novel Treatment for Opioid Dependence
$922,540Michael M Morgan · Washington State University · UG3 · FY2019 · DA
Immunomodulatory Therapy for Neuropathic Pain
$922,476Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2022 · NS
Recovery Management Checkups for Women Offenders (RMC-WO) Experiment
$922,340Christy K Scott · Chestnut Health Systems, Inc. · R01 · FY2010 · DA
Sparking Advancements in Genomic Medicine
$922,335Julie A. Johnson · University Of Florida · U01 · FY2018 · HG
BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO)
$922,304Peter C Michels · Albany Molecular Research, Inc. · N01 · FY2025 · DA
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids
$922,170Bonnie Berger · Massachusetts Institute Of Technology · U01 · FY2022 · CA
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids
$922,170Timothy Lu · Massachusetts Institute Of Technology · U01 · FY2020 · CA
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids
$922,170Timothy Lu · Massachusetts Institute Of Technology · U01 · FY2021 · CA
Characterization And Pharmacology Of Receptors For Gastrointestinal Peptides
$922,054Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model
$921,821Peter W Kalivas · Medical University Of South Carolina · U01 · FY2021 · DA
Repressive Histone and DNA Methylation in Stimulant and Opiate Addiction
$921,253Eric J Nestler · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · DA
Targeting undruggable RAS for cancer treatment
$921,017Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2021 · CA